Obsidian Therapeutics
Obsidian Therapeutics is seeking a highly motivated data scientist to lead advanced analytics and statistical modeling for cell and gene therapy manufacturing processes. This strategic role involves defining data infrastructure, delivering real-time monitoring dashboards, and translating complex datasets into actionable insights to support late-stage clinical development and regulatory submissions. The position requires strong CMC domain expertise and cross-functional collaboration to drive compliant integration of AI/ML tools and accelerate manufacturing intelligence.
Headquarters
Cambridge, Massachusetts, United States
Obsidian Therapeutics is a clinical-stage biotechnology company using its proprietary cytoDRiVE® platform to engineer novel TIL (tumor-infiltrating lymphocyte) cell therapies. The platform leverages drug-responsive domains (DRDs) to regulate protein function using an FDA-approved small-molecule drug. The company's lead program, OBX-115 (amsoki-cel), is being evaluated in advanced melanoma in a Phase 1/2 clinical trial.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Obsidian Therapeutics.
AS&T Principal Scientist - CGT & Biologics
Vertex
Associate Principal Scientist, Statistical Programming – Rahway, NJ
Merck & Co., Inc.
Associate Principal Scientist, Statistical Programming – Rahway, NJ
Merck & Co., Inc.
Director, Process Data Science and Statistics lead
AstraZeneca
Associate Director, CMC Statistician
Vaxcyte
Associate Principal Scientist, Biologics Process R&D
Merck & Co., Inc.